Ken Page
Impact in
- Pharmacology top 2%
- Pharmacogenetics and Drug Metabolism
- Drug-Induced Hepatotoxicity and Protection
- Oncology top 10%
- Drug Transport and Resistance Mechanisms
Papers in
-
- Biochemical and Molecular Research 5
- PI3K/AKT/mTOR signaling in cancer 5
- Bone Metabolism and Diseases 4
-
- Pharmacogenetics and Drug Metabolism 4
- Co-authors
- Emre Mehmet Isin (2 shared papers)Richard John Weaver (2 shared papers)Yan Li (2 shared papers)Lars O. G. Weidolf (2 shared papers)Ian D. Wilson (2 shared papers)Hugues Dolgos (2 shared papers)Richard A. Thompson (2 shared papers)J. Gerry Kenna (2 shared papers)
- Journals
- Bioorganic & Medicinal Chemistry Letters (13 papers)Journal of Medicinal Chemistry (5 papers)Sensors and Actuators B Chemical (2 papers)Chemical Research in Toxicology (1 paper)Chemico-Biological Interactions (1 paper)
- Partner nations
- United KingdomUnited StatesSweden
In The Last Decade
Ken Page
27 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 99
- Pharmacology 228
- Oncology 334
- Organic Chemistry 358
- Molecular Biology 788
- Cancer Research 136
Countries citing papers authored by Ken Page
This map shows the geographic impact of Ken Page's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Ken Page with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Ken Page more than expected).
Fields of papers citing papers by Ken Page
This network shows the impact of papers produced by Ken Page. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Ken Page. The network helps show where Ken Page may publish in the future.
Co-authors
The 25 scholars most cited alongside Ken Page, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 27 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2012 | 410 | |
| 2 | 2013 | 199 | |
| 3 | 2013 | 192 | |
| 4 | 2012 | 178 | |
| 5 | 2003 | 141 | |
| 6 | 2010 | 81 | |
| 7 | 2015 | 52 | |
| 8 | 2004 | 43 | |
| 9 | 2012 | 36 | |
| 10 | 2015 | 32 | |
| 11 | 2008 | 24 | |
| 12 | 2012 | 20 | |
| 13 | 2013 | 20 | |
| 14 | 1998 | 19 | |
| 15 | 2015 | 17 | |
| 16 | 2011 | 15 | |
| 17 | 2009 | 13 | |
| 18 | 2011 | 13 | |
| 19 | 1998 | 12 | |
| 20 | 2009 | 12 |
About Ken Page
Ken Page is a scholar working on Molecular Biology, Pharmacology, Genetics, Cancer Research and Immunology and Allergy, having authored 27 papers that have together received 1.6k indexed citations. Recurring topics across this work include Biochemical and Molecular Research (5 papers), PI3K/AKT/mTOR signaling in cancer (5 papers), Chronic Lymphocytic Leukemia Research (4 papers), Pharmacogenetics and Drug Metabolism (4 papers), Bone Metabolism and Diseases (4 papers), Analytical Chemistry and Chromatography (3 papers), Protease and Inhibitor Mechanisms (3 papers) and Computational Drug Discovery Methods (3 papers). The work is most often cited by research in Pharmacology (228 citations), Oncology (334 citations), Organic Chemistry (358 citations), Molecular Biology (788 citations) and Cancer Research (136 citations). Ken Page has collaborated with scholars based in United Kingdom, United States and Sweden. Frequent co-authors include Emre Mehmet Isin, Richard John Weaver, Yan Li, Lars O. G. Weidolf, Ian D. Wilson, Hugues Dolgos, Richard A. Thompson, J. Gerry Kenna, Brian J. Middleton and Alison J. Foster. Their work appears in journals such as Bioorganic & Medicinal Chemistry Letters, Journal of Medicinal Chemistry, Sensors and Actuators B Chemical, Chemical Research in Toxicology and Chemico-Biological Interactions.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.